Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Placebo-controlled, Parallel Group, Study to Evaluate the Efficacy and Safety of VR506 Inhaled From a New Inhaler in Adolescent and Adult Subjects With Asthma

NCT01472757 is registered in ClinicalTrials.gov with Vectura Limited as lead sponsor.

NCT NCT01472757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01472757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Placebo-controlled, Parallel Group, Study to Evaluate the Efficacy and Safety of VR506 Inhaled From a New Inhaler in Adolescent and Adult Subjects With Asthma
Lead sponsor
Vectura Limited
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2011
Completion date
May 31, 2013
Enrollment
374 (actual)
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

asthma